Bexsero, Injektionssuspension

7680657300048 CH-65730 Injektionssuspension

No image available

Article details

Package size
10
Selling units
10
Measure
Fertigspritze(n)
Galenic form
Injektionssuspension
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
05/05/2026
Summary of Product Characteristics
Français
05/05/2026
Summary of Product Characteristics
Italien
05/05/2026

Detailed composition

Substance Quantity Type Category
proteinum fusionatum NHBA neisseriae meningitidis B
50.0 UG Substance Wirkstoff (Principe actif)
proteinum NadA neisseriae meningitidis B
50.0 UG Substance Wirkstoff (Principe actif)
proteinum fusionatum fHbp neisseriae meningitidis B
50.0 UG Substance Wirkstoff (Principe actif)
vesicula membranae exterioris (OMV) ex Neisseria meningitidis B
25.0 UG Substance Wirkstoff (Principe actif)
aluminium
0.5 MG Substance HNIDK
aluminii hydroxidum hydricum ad adsorptionem
- Substance HNIDK
histidinum
- Substance HNIDK
natrii chloridum
- Substance HNIDK
saccharum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
1.2 MG Substance HBESI

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
65730
Drug name
Bexsero, Injektionssuspension
Galenic form
INJFS
ATC Code
J07AH09
Authorization status
Z
Dispensing category
B
First authorization
23/11/2017
Authorization expiration date
31/12/9999
IT Number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Meningokokken-Meningitis der Serogruppe B

Package details

Description (FR)
BEXSERO susp inj ser pré 0.5 ml 10 pce
Description (DE)
BEXSERO Inj Susp Fertspr 0.5 ml 10 Stk
Market launch
01/03/2026
Narcotic (BTM)
No

Other package sizes (2)

BEXSERO susp inj (#) ser pré 0.5 ml
None None
GTIN: 7680657300017
Not in V1
BEXSERO susp inj ser pré 0.5 ml
1 FESP
GTIN: 7680657300031
View
Buy us a coffee Explore the data